Blockchain Registration Transaction Record
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and Highlights Progress in 2024
Stonegate Capital Partners initiates coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and its flagship Alzheimer's therapy ZUNVEYL. With FDA approval and upcoming launch, Alpha Cognition aims to provide a well-tolerated treatment option for Alzheimer's patients, addressing the high discontinuation rate due to side effects.
This news matters as Alpha Cognition's innovative Alzheimer's therapy ZUNVEYL has the potential to address the unmet needs in the treatment of AD. With a strong management team, financial stability, and global expansion plans, Alpha Cognition is positioned for rapid adoption and long-term success in the market.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x149d3b22328b0df6c5e8f2ef3db1224fb9ffc43182fedd24b2604d56cfd4eadf |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | camcXRsK-5d19ee71eb0ed27207e879f801ce58d8 |